Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.
about
Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptorAssociation of a RING finger protein with the cytoplasmic domain of the human type-2 tumour necrosis factor receptorFlow cytometric analysis of cytokine receptors on human Langerhans' cells. Changes observed after short-term cultureTRUSS, a novel tumor necrosis factor receptor 1 scaffolding protein that mediates activation of the transcription factor NF-kappaBPolymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptorHigh resolution crystal structure of a human tumor necrosis factor-alpha mutant with low systemic toxicityMolecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factorMolecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells.A phage-displayed mimotope inhibits tumour necrosis factor-alpha-induced cytotoxicity more effectively than the free mimotope.Molecular cloning, expression and characterization of ovine TNF alpha.Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritisLung chitinolytic activity and chitotriosidase are elevated in chronic obstructive pulmonary disease and contribute to lung inflammation.Circulating tumor necrosis factor alpha (TNF), soluble TNF receptors, and interleukin-6 in human subacute bacterial endocarditis.TNF-TNFR2/p75 signaling inhibits early and increases delayed nontargeted effects in bone marrow-derived endothelial progenitor cells.Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.Thymocyte-thymic epithelial cell interaction leads to high-level replication of human immunodeficiency virus exclusively in mature CD4(+) CD8(-) CD3(+) thymocytes: a critical role for tumor necrosis factor and interleukin-7.The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?Etanercept: therapeutic use in patients with rheumatoid arthritisHypersensitivity of Vagal Pulmonary Afferents Induced by Tumor Necrosis Factor Alpha in Mice.Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor.Autocrine and paracrine growth inhibitors of breast cancer cells.Functional switching of macrophage responses to tumor necrosis factor-alpha (TNF alpha) by interferons. Implications for the pleiotropic activities of TNF alpha.Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality.The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers - a meta-analysisAntagonistic TNF receptor one-specific antibody (ATROSAB): receptor binding and in vitro bioactivityPrediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.The therapeutic potential of interleukin-1 and tumor necrosis factor on hematopoietic stem cells.Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells.An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor.Do soluble p55 and p75 TNF-α receptor concentrations play a role in women with primary sterility?Tumor necrosis factor-alpha acts as a complete mitogen for primary rat hepatocytesDisparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells.Expression of tumor necrosis factor-alpha and its mRNA in the endometrial mucosa during the menstrual cycle.Role of the 75-kDa tumor necrosis factor receptor: inhibition of early hematopoiesis.
P2860
Q24315622-36DEC641-56A1-4148-B633-F532BD77AB1EQ24528198-79A04A0A-96EA-4DD0-93BB-CD2C5DFA6B82Q24541457-51BB36F9-F870-44CA-9A3D-840861C1C096Q24649790-79994124-9BB8-4F2A-9BE6-EAE249AE3E7FQ24812785-534AF755-30FC-4C60-AF98-32FC684AA012Q27730254-BEC12930-F64E-4A9A-A87D-AC09C36BB15FQ27748818-55D63695-C911-489A-8252-86261DFB6435Q28512161-951C1554-B2D3-46B6-BC3F-C3320556F0B9Q30480303-AA6C00E1-94DB-4EF7-8EED-657F7669B917Q30629470-1E37A91C-9404-4EE1-8E44-90D3A0651B0AQ30834362-BD732406-DFE2-4122-AF86-5441F9E3B1A8Q33336314-1FF55013-C4BA-45AB-B3E8-FC2D8BFCBF76Q33578865-9FE09FE4-8E14-4D09-ACC3-E964A89880A6Q33597102-A5627F7D-242E-4153-9E36-2EE8EFF3840FQ33618298-51D0AAFF-35CB-426D-9427-1BF960501CCCQ33619488-89DC241B-4DC0-480C-BE52-94C77473A814Q33641577-8F244E8B-51BF-43DF-83C8-A35A467F5691Q33649854-61AF4F3C-ACCC-442F-BC73-7466CD403220Q33662836-C46916E3-B4D7-4418-A18F-4E789B846794Q33782355-EEFEEB40-C4A1-4E1D-B48C-D1A386596E92Q33795087-124ED2DE-8974-4942-9A4D-8310B17536D4Q33891000-AAE14D25-C6AD-4BAA-9545-B3C1A1E17046Q33899892-66E33AFE-3900-401B-81D4-42E5AC8CBBDCQ33937497-3B45DF48-ACF4-4DC7-8768-30BEC34D5A08Q33993767-A45C53C1-6903-4694-A9FC-DEBF0AC58C0FQ34140551-BA3A8889-3D06-4876-82FC-BC8290461F18Q34409484-0A87D1B3-029B-45DE-A1D5-98F80D9B8801Q34607576-3D6F1663-2ACB-4390-96D9-E7D1E97045E1Q34631136-E680D441-F7EF-427E-BC9B-CBBFED176BDAQ34973492-B1DB09F2-290C-443C-8A93-18BBF919E1CBQ35112864-AAB8064E-5A5C-4608-9CDC-51E074F6FC7DQ35196479-2ED5A04E-707D-41F8-AC71-227E3CD8D40AQ35609177-34AEBF03-25BE-4AA1-BBDB-AC71F22AFBA9Q35694784-C1BF051A-CDB5-4434-9346-8FA3831E7057Q35739690-E7C3DC6C-A5CD-4615-A779-A961D5658CCFQ35762046-BEB1A91D-3858-4710-980B-4BA377EDCA11Q35791667-0ADABCD3-093A-486D-8059-03D7228B5543Q35797945-3D61588A-F7AF-4E0E-8097-5927DCF461ADQ35833094-750FB430-1D4E-4D8A-A5F2-98821406C8FEQ35869650-B537DED8-AB01-4AB5-ADE3-3C5F22768E5D
P2860
Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of two types of ...... ines by monoclonal antibodies.
@en
Identification of two types of ...... ines by monoclonal antibodies.
@nl
type
label
Identification of two types of ...... ines by monoclonal antibodies.
@en
Identification of two types of ...... ines by monoclonal antibodies.
@nl
prefLabel
Identification of two types of ...... ines by monoclonal antibodies.
@en
Identification of two types of ...... ines by monoclonal antibodies.
@nl
P2093
P2860
P4510
P356
P1476
Identification of two types of ...... ines by monoclonal antibodies.
@en
P2093
Brockhaus M
Hunziker W
Lesslauer W
Loetscher H
Schlaeger EJ
Schoenfeld HJ
P2860
P304
P356
10.1073/PNAS.87.8.3127
P407
P577
1990-04-01T00:00:00Z